Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Examining Prenylated Xanthones as Potential Inhibitors Against Ketohexokinase C Isoform for the Treatment of Fructose-Driven Metabolic Disorders: An Integrated Computational ApproachTilal Elsaman, Magdi Awadalla Mohamed
Bioorganic Chemistry|May 12, 2019
Current development of 5-nitrofuran-2-yl derivatives as antitubercular agentsTilal Elsaman, Malik Suliman Mohamed, Magdi A Mohamed
Current Pharmacology Reports|April 1, 2020
Ellagic Acid, Kaempferol, and Quercetin from Acacia nilotica: Promising Combined Drug With Multiple Mechanisms of ActionMosab Yahya Al-Nour, Musab Mohamed Ibrahim, Tilal Elsaman
International Journal of Medicinal Chemistry|July 17, 2018
Synthesis, Anti-Inflammatory Activity, and In Silico Study of Novel Diclofenac and Isatin ConjugatesMusab Mohamed Ibrahim, Tilal Elsaman, Mosab Yahya Al-Nour
International Journal of Nanomedicine|May 9, 2022
Synthesis, Characterization, Functionalization and Bio-Applications of Hydroxyapatite Nanomaterials: An OverviewMuhammad Usman Munir, Sajal Salman, Ayehsa Ihsan, et al.
Bioorganic Chemistry|January 2, 2017
Synthesis, characterization and pharmacological evaluation of certain enzymatically cleavable NSAIDs amide prodrugsTilal Elsaman, Omar A A Aldeeb, Tarek Aboul-Fadl, et al.
Molecules (Basel, Switzerland)|February 8, 2013
The reaction of ethyl 2-oxo-2H-chromene-3-carboxylate with hydrazine hydrateHatem A Abdel-Aziz, Tilal Elsaman, Mohamed I Attia, et al.
Frontiers in Chemistry|February 7, 2025
Microbial-based natural products as potential inhibitors targeting DNA gyrase B of Mycobacterium tuberculosis: an in silico studyTilal Elsaman, Magdi Awadalla Mohamed, Malik Suliman Mohamed, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 21, 2020
Xanthone: A Promising Antimycobacterial ScaffoldTilal Elsaman, Malik Suliman Mohamed, Eyman Mohamed Eltayib, et al.
Pharmaceuticals (Basel, Switzerland)|April 26, 2025
Identification of Microbial-Based Natural Products as Potential CYP51 Inhibitors for Eumycetoma Treatment: Insights from Molecular Docking, MM-GBSA Calculations, ADMET Analysis, and Molecular Dynamics SimulationsTilal Elsaman, Mohamed Khalid Alhaj Awadalla, Malik Suliman Mohamed, et al.
Pageof 4